发明申请
US20080118549A1 SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR TREATING OCULAR VASCULOPATHIES
有权
可持续发布的内窥镜植入物和治疗卵巢血管病的方法
- 专利标题： SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR TREATING OCULAR VASCULOPATHIES
- 专利标题（中）： 可持续发布的内窥镜植入物和治疗卵巢血管病的方法
-
申请号： US12024017申请日： 2008-01-31
-
公开(公告)号： US20080118549A1公开(公告)日： 2008-05-22
- 发明人: Glenn HUANG , Brittany Jackson , James Burke , Ton Lin , Patrick Hughes , Larry Wheeler , Rosy Donn
- 申请人： Glenn HUANG , Brittany Jackson , James Burke , Ton Lin , Patrick Hughes , Larry Wheeler , Rosy Donn
- 申请人地址： US CA Irvine
- 专利权人： ALLERGAN, INC.
- 当前专利权人： ALLERGAN, INC.
- 当前专利权人地址： US CA Irvine
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K31/502 ; A61P27/16
摘要：
Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat one or more ocular conditions, such as an ocular vasculopathy or glaucoma, among others.
公开/授权文献
信息查询
